Lenalidomide in chronic lymphocytic leukemia: the present and future in the era of tyrosine kinase inhibitors.
about
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia.Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia.Recent advances in therapy of chronic lymphocytic leukaemia.LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia.Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide.IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML
P2860
Q33436535-CA68783A-C6A3-48B5-9B2D-F88ED5B19CF5Q38783064-7C06DE87-C5CB-4CE6-880B-82BA40011C99Q38818283-E847E92E-C011-442A-BB03-5EC36366B4EAQ38862525-38D94415-A70E-40F5-A52B-DAB660BCD64AQ49818481-22D4E4B0-0B26-4D8B-B4A7-C993CC615A3AQ50864223-B645EDFF-E906-43A4-A8AA-17BA2CB3C94AQ57927278-EF87EB49-EF88-4481-A28B-5108B9BDE16A
P2860
Lenalidomide in chronic lymphocytic leukemia: the present and future in the era of tyrosine kinase inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lenalidomide in chronic lympho ...... of tyrosine kinase inhibitors.
@en
type
label
Lenalidomide in chronic lympho ...... of tyrosine kinase inhibitors.
@en
prefLabel
Lenalidomide in chronic lympho ...... of tyrosine kinase inhibitors.
@en
P50
P1476
Lenalidomide in chronic lympho ...... of tyrosine kinase inhibitors
@en
P2093
Elisabetta Colaci
Stefania Fiorcari
P304
P356
10.1016/J.CRITREVONC.2015.09.003
P577
2015-09-30T00:00:00Z